Inhibrx Biosciences INBX
NASDAQ INBX
$96.99 -0.94 (-0.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inhibrx Biosciences (INBX) Other Non Operating Income (2023 - 2026)

Updated

Inhibrx Biosciences (INBX) recorded Other Non Operating Income of -$68,000 in Q2 2026, compared with -$246,000 a year earlier.

Analysis

Inhibrx Biosciences (INBX) Other Non Operating Income (2023 - 2026) Analysis & Trends

On a TTM basis, Inhibrx Biosciences' Other Non Operating Income came in at -$399,000 as of Jun 30, 2026; for FY2025, it came in at -$381,000.

  • Across earlier years, Other Non Operating Income came in at $75,000 in FY2024 and -$580,000 in FY2023.
  • Quarterly Other Non Operating Income has ranged from -$246,000 in Q2 2025 to $60,000 in Q4 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Inhibrx Biosciences 1.44 Bn 1.44 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -68,000.00
Dec 31, 2025 -39,000.00
Sep 30, 2025 -46,000.00
Jun 30, 2025 -246,000.00
Mar 31, 2025 -50,000.00
Dec 31, 2024 60,000.00
Sep 30, 2024 41,000.00
Jun 30, 2024 33,000.00
Mar 31, 2024 -59,000.00
Dec 31, 2023 -158,000.00
Sep 30, 2023 -135,000.00
Jun 30, 2023 -217,000.00
API Access

Inhibrx Biosciences Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=INBX&period=max&api_key=YOUR_API_KEY